Market News

Moderna Inc. (NASDAQ:MRNA) Affirms COVID-19 Vaccine Prospects after Pfizer Inc. (NYSE:PFE) Breakthrough

The race for the next big thing in the fight against the coronavirus is heating up. Moderna Inc. (NASDAQ:MRNA) has already confirmed plans to release its vaccine candidate. The company has finished the enrollment of participants as part of its 30,000 volunteer study.

Moderna COVID Trials

Moderna is on course to report early data from the late-stage trial of is experimental vaccine next month. The drug maker has already appointed an independent data monitoring committee that is expected to conduct an interim review of the ongoing 30,000-person trial.

In addition, the drug maker plans to distribute the mRNA-1273 vaccine. Plans are already underway to produce 20 million doses before the end of the year and between 500 million to 1 billion dosses by 2021.

Distribution of the experimental vaccine would depend on the drug maker securing regulatory green line. A milestone of such status would be a major endorsement for the biotech vaccine platform that uses messenger RNA to mimic the surface of the coronavirus and teach the immune system to neutralize the virus.

While the technology is yet to produce an approved vaccine, it is on the spot on Pfizer Inc. (NYSE: PFE) announcing that its experimental vaccine is 90% effective in fighting the virus. Pfizer becomes the first drug maker to make a claim over the effectiveness of its experimental vaccine.

>> Trade on the movements of Moderna with easy markets<<

Coronavirus Toll

For Moderna, it is a waiting game as it awaits two months of follow up data to affirm the safety levels of its experimental vaccine. The safety data required by the U.S Food and Drug Administration would be made available in the second half of November.

A coronavirus vaccine is highly needed as the globe faces a second wave of infection that continues to take a toll on various activities. The U.S has already recorded over one million cases over the past ten days, with total infections rising to over 10 million.

Europe is also battling a resurgence of infections, with some countries led by France, the U.K, and Germany resorting to lockdown measures in a bid to curtail further infections.

Merry Markets is the home of free financial news and analysis on Forex, Stocks and cryptocurrencies. Check out our latest trading guides on best bitcoin trading brokers, Top FX Trading Brokers, and Spread Betting Brokers. Follow our reviews on Easy Markets Website, Website and City Index Forex Trading broker.

Ruchi Gupta

Ruchi Gupta covers various beats from finance to technology and from lifestyle to hobbies. She has an MBA in Finance. Ruchi enjoys writing on celebrities and political news. She likes traveling and exploring places.

Related Articles

Back to top button